UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

Nature genetics, 2009-01, Vol.41 (1), p.71-76

2009

Volltextzugriff (PDF)

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2019-10, Vol.157 (4), p.997-1006.e6

2019

Volltextzugriff (PDF)

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Nature genetics, 2013-09, Vol.45 (9), p.984-994

2013

Volltextzugriff (PDF)

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Nature genetics, 2023-05, Vol.55 (5), p.796-806

2023

Volltextzugriff (PDF)

Mo1558: REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB FOR MODERATE-SEVERE MULTI-REFRACTORY CROHN’S DISEASE: RESULTS FROM A BELGIAN MULTI-CENTRIC COHORT

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-818-S-819

2022

Volltextzugriff (PDF)

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Nature genetics, 2013-06, Vol.45 (6), p.670-675

2013

Volltextzugriff (PDF)

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

Nature genetics, 2011-03, Vol.43 (3), p.246-52

2011

Volltextzugriff (PDF)

456 EFFICACY, SAFETY AND MUCOSAL HEALING OF EARLY VERSUS LATE USE OF VEDOLIZUMAB IN ULCERATIVE COLITIS: RESULTS FROM THE LOVE-UC STUDY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-91-S-92

2021

Volltextzugriff (PDF)

731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-176-S-177

2024

Volltextzugriff (PDF)

Common variants at five new loci associated with early-onset inflammatory bowel disease

Nature genetics, 2009-12, Vol.41 (12), p.1335-1340

2009

Volltextzugriff (PDF)

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-919-S-920

2023

Volltextzugriff (PDF)

Mo1816 NEOPLASTIC LESIONS OUTSIDE DISEASED AREA IN IBD PATIENTS: A NATIONAL COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-935-S-935

2020

Volltextzugriff (PDF)

Sa1864 PROSPECTIVE STUDY OF PHARMACOKINETICS OF INFLIXIMAB DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS (PACIFIC)

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-456-S-456

2020

Volltextzugriff (PDF)

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2023-10, Vol.165 (4), p.946-962.e13

2023

Volltextzugriff (PDF)

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-95-S-96

2022

Volltextzugriff (PDF)

An insertion–deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

Human molecular genetics, 2007-12, Vol.16 (24), p.3008-3016

2007

Volltextzugriff (PDF)

A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103− dendritic cells

The Journal of experimental medicine, 2009-08, Vol.206 (9), p.1995-2011

2009

Volltextzugriff (PDF)

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

The FASEB journal, 2002-01, Vol.16 (1), p.61-71

2002

Volltextzugriff (PDF)

144 – Postoperative Endoscopic and Clinical Recurrence After Ileocolonic Resection in Patients with Crohn's Disease Cannot Be Prevented with High Dose Vitamin D

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-33-S-33

2019

Volltextzugriff (PDF)

Tu1895 TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1208-S-1208

2020

Volltextzugriff (PDF)

Sa1942 Infliximab Trough Level Measured During Treatment Induction May Be Predictive of the Loss of Response to Infliximab During Treatment Maintenance in Inflammatory Bowel Disease Patients: A Longitudinal Observational Retrospective Study

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S411-S411

2016

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

ThemaFemale

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(73)
Webseiten
(6)

Sprache

Englisch
(78)
Französisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries

Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease

Mo1558: REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB FOR MODERATE-SEVERE MULTI-REFRACTORY CROHN’S DISEASE: RESULTS FROM A BELGIAN MULTI-CENTRIC COHORT

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

456 EFFICACY, SAFETY AND MUCOSAL HEALING OF EARLY VERSUS LATE USE OF VEDOLIZUMAB IN ULCERATIVE COLITIS: RESULTS FROM THE LOVE-UC STUDY

731 FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY

Common variants at five new loci associated with early-onset inflammatory bowel disease

Mo1810 BASELINE RNA AND MICROBIOTA SIGNATURES ARE ASSOCIATED WITH RESPONSE AND GENERAL DECREASE IN BACTEROIDES-2 ENTEROTYPE AFTER FMT IN UC

Mo1816 NEOPLASTIC LESIONS OUTSIDE DISEASED AREA IN IBD PATIENTS: A NATIONAL COHORT STUDY

Sa1864 PROSPECTIVE STUDY OF PHARMACOKINETICS OF INFLIXIMAB DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS (PACIFIC)

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

440: STANDARDIZED FECAL MICROBIOTA TRANSPLANTATION THROUGH MICROBIOME-GUIDED DONOR SELECTION IN ACTIVE ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED INTERVENTION STUDY

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

An insertion–deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103− dendritic cells

Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn’s Disease

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

144 – Postoperative Endoscopic and Clinical Recurrence After Ileocolonic Resection in Patients with Crohn's Disease Cannot Be Prevented with High Dose Vitamin D

Tu1895 TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

Sa1942 Infliximab Trough Level Measured During Treatment Induction May Be Predictive of the Loss of Response to Infliximab During Treatment Maintenance in Inflammatory Bowel Disease Patients: A Longitudinal Observational Retrospective Study

Aktive Filter

Suchergebnisse filtern